A Retrospective Time Trend Study Of Diabetes Overtreatment In Geriatric Patients

References

• McDonald M , Hertz RP , Unger AN , Lustik MB . Prevalence, awareness, and management of hypertension, dyslipidemia, and diabetes among United States adults aged 65 and older. J Gerontol A Biol Sci Med Sci . 2009;64(2):256–263. doi:10.1093/gerona/gln016 19181717
   PubMed Web of Science ®Google Scholar
• Du Y , Heidemann C , Gosswald A , Schmich P , Scheidt-Nave C . Prevalence and comorbidity of diabetes mellitus among non-institutionalized older adults in Germany - results of the national telephone health interview survey ‘German Health Update (GEDA)’ 2009. BMC Public Health . 2013;13:166. doi:10.1186/1471-2458-13-166 23433228
   PubMed Web of Science ®Google Scholar
• Sanchez Martinez M , Blanco A , Castell MV , et al. Diabetes in older people: prevalence, incidence and its association with medium- and long-term mortality from all causes. Aten Primaria . 2014;46(7):376–384. doi:10.1016/j.aprim.2013.12.004 24576691
   PubMed Web of Science ®Google Scholar
• Yang YC , Lin MH , Wang CS , et al. Geriatric syndromes and quality of life in older adults with diabetes. Geriatr Gerontol Int . 2019. doi:10.1111/ggi.13654
   Web of Science ®Google Scholar
• Espelt A , Borrell C , Palencia L , et al. Socioeconomic inequalities in the incidence and prevalence of type 2 diabetes mellitus in Europe. Gac Sanit . 2013;27(6):494–501. doi:10.1016/j.gaceta.2013.03.002 23643719
   PubMed Web of Science ®Google Scholar
• American Diabetes A. 6. Glycemic targets: standards of medical care in diabetes-2019. Diabetes Care . 2019;42(Suppl 1):S61–S70. doi:10.2337/dc19-S006 30559232
   PubMed Web of Science ®Google Scholar
• American Diabetes A. 12. Older adults: standards of medical care in diabetes-2019. Diabetes Care . 2019;42(Suppl 1):S139–S147. doi:10.2337/dc19-S012 30559238
   PubMedGoogle Scholar
• Diabetes Poland. 2019 Guidelines on the management of diabetic patients. A position of Diabetes Poland. Clin Diabetol . 2019;8(1):1–97. doi:10.5603/DK.2019.0001
   Web of Science ®Google Scholar
• Yun JS , Ko SH . Risk factors and adverse outcomes of severe hypoglycemia in type 2 diabetes mellitus. Diabetes Metab J . 2016;40(6):423–432. doi:10.4093/dmj.2016.40.6.423 27766794
   PubMed Web of Science ®Google Scholar
• Thorpe CT , Gellad WF , Good CB , et al. Tight glycemic control and use of hypoglycemic medications in older veterans with type 2 diabetes and comorbid dementia. Diabetes Care . 2015;38(4):588–595. doi:10.2337/dc14-0599 25592195
   PubMed Web of Science ®Google Scholar
• Lipska KJ , Ross JS , Miao Y , Shah ND , Lee SJ , Steinman MA . Potential overtreatment of diabetes mellitus in older adults with tight glycemic control. JAMA Intern Med . 2015;175(3):356–362. doi:10.1001/jamainternmed.2014.7345 25581565
   PubMed Web of Science ®Google Scholar
• Muller N , Khunti K , Kuss O , et al. Is there evidence of potential overtreatment of glycaemia in elderly people with type 2 diabetes? Data from the GUIDANCE study. Acta Diabetol . 2017;54(2):209–214.27837286
   PubMed Web of Science ®Google Scholar
• Wojszel ZB , Kasiukiewicz A . A retrospective cross-sectional study of type 2 diabetes overtreatment in patients admitted to the geriatric ward. BMC Geriatr . 2019;19(1):242. doi:10.1186/s12877-019-1256-2 31477024
   PubMed Web of Science ®Google Scholar
• Polish Diabetes Association. Clinical recommendations for the management of patients with diabetes 2011. Diabetol Prakt . 2011;12:(Suppl A):A1-A46.
   Google Scholar
• Kasiukiewicz A , Wojszel ZB , Klimiuk K , Kuprjanowicz B , Bień B . The prevalence of the frailty syndrome among patients admitted to a geriatric ward – a retrospective study. Paper presented at: 4th International Medical Congress A Women and a Man 65+. How to treat and care for? 11 17–18; 2017; Warsaw, Poland.
   Google Scholar
• Cockcroft DW , Gault MH . Prediction of creatinine clearance from serum creatinine. Nephron . 1976;16(1):31–41. doi:10.1159/000180580 1244564
   PubMed Web of Science ®Google Scholar
• Mahoney FI , Barthel DW . Functional evaluation: the barthel index. Md State Med J . 1965;14:61–65.
   PubMedGoogle Scholar
• Fillenbaum GG , Smyer MA . The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. J Gerontol . 1981;36(4):428–434. doi:10.1093/geronj/36.4.428 7252074
   PubMedGoogle Scholar
• Norton D , McLaren R , Exton-Smith AN . An Investigation of Geriatric Nursing Problems in Hospital . Edinburgh; New York: Churchill Livingstone; 1975.
   Google Scholar
• Boussageon R , Bejan-Angoulvant T , Saadatian-Elahi M , et al. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ . 2011;343:d4169. doi:10.1136/bmj.d4169 21791495
   PubMed Web of Science ®Google Scholar
• Hubbard RE , Andrew MK , Fallah N , Rockwood K . Comparison of the prognostic importance of diagnosed diabetes, co-morbidity and frailty in older people. Diabet Med . 2010;27(5):603–606. doi:10.1111/j.1464-5491.2010.02977.x 20536960
   PubMed Web of Science ®Google Scholar
• Wojszel ZB , Kasiukiewicz A , Klimiuk K , Wojskowicz A . Control of carbohydrate metabolism in patients with diabetes admitted to the geriatrics department - retrospective analysis [Polish]. Diabetol Klin . 2013;2(2):68.
   Google Scholar
• Hay LC , Wilmshurst EG , Fulcher G . Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring. Diabetes Technol Ther . 2003;5(1):19–26. doi:10.1089/152091503763816427 12725703
   PubMedGoogle Scholar
• Diabetes Control Complications Trial Research Group, Nathan DM , Genuth S , et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med . 1993;329(14):977–986. doi:10.1056/NEJM199309303291401 8366922
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet . 1998;352(9131):837–853.9742976
   PubMed Web of Science ®Google Scholar
• Lipska KJ , Warton EM , Huang ES , et al. HbA1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study. Diabetes Care . 2013;36(11):3535–3542. doi:10.2337/dc13-0610 23900589
   PubMed Web of Science ®Google Scholar
• Ishikawa T , Koshizaka M , Maezawa Y , et al. Continuous glucose monitoring reveals hypoglycemia risk in elderly patients with type 2 diabetes mellitus. J Diabetes Investig . 2018;9(1):69–74. doi:10.1111/jdi.12676
   Web of Science ®Google Scholar
• Roth J , Muller N , Lehmann T , Heinemann L , Wolf G , Muller UA . HbA1c and age in non-diabetic subjects: an ignored association? Exp Clin Endocrinol Diabetes . 2016;124(10):637–642. doi:10.1055/s-0042-105440 27219885
   PubMed Web of Science ®Google Scholar
• Prinz N , Stingl J , Dapp A , et al. High rate of hypoglycemia in 6770 type 2 diabetes patients with comorbid dementia: a multicenter cohort study on 215,932 patients from the German/Austrian diabetes registry. Diabetes Res Clin Pract . 2016;112:73–81. doi:10.1016/j.diabres.2015.10.026 26563590
   PubMed Web of Science ®Google Scholar
• Alsahli M , Gerich JE . Hypoglycemia in patients with diabetes and renal disease. J Clin Med . 2015;4(5):948–964. doi:10.3390/jcm4050948 26239457
   PubMed Web of Science ®Google Scholar
• Nicolucci A , Prosperini G , Buzzetti R , et al. A multistep approach for the stratification of the risk of severe hypoglycemia in patients with type 2 diabetes. Minerva Endocrinol . 2018;43(4):501–510. doi:10.23736/S0391-1977.18.02850-X 30463398
   PubMed Web of Science ®Google Scholar
• Borzi V , Frasson S , Gussoni G , et al. Risk factors for hypoglycemia in patients with type 2 diabetes, hospitalized in internal medicine wards: findings from the FADOI-DIAMOND study. Diabetes Res Clin Pract . 2016;115:24–30. doi:10.1016/j.diabres.2016.01.020 27242119
   PubMed Web of Science ®Google Scholar
• Yu S , Fu AZ , Engel SS , Shankar RR , Radican L . Association between hypoglycemia risk and hemoglobin A1C in patients with type 2 diabetes mellitus. Curr Med Res Opin . 2016;32(8):1409–1416. doi:10.1080/03007995.2016.1176017 27053004
   PubMed Web of Science ®Google Scholar
• Karter AJ , Warton EM , Lipska KJ , et al. Development and validation of a tool to identify patients with type 2 diabetes at high risk of hypoglycemia-related emergency department or hospital use. JAMA Intern Med . 2017;177(10):1461–1470. doi:10.1001/jamainternmed.2017.3844 28828479
   PubMed Web of Science ®Google Scholar
• American Diabetes A. 9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2019. Diabetes Care . 2019;42(Suppl 1):S90–S102. doi:10.2337/dc19-S009 30559235
   PubMed Web of Science ®Google Scholar
• Yu O , Azoulay L , Yin H , Filion KB , Suissa S . Sulfonylureas as initial treatment for type 2 diabetes and the risk of severe hypoglycemia. Am J Med . 2018;131(3):317e31–317e322. doi:10.1016/j.amjmed.2017.09.044
   Web of Science ®Google Scholar
• Muller N , Lehmann T , Gerste B , et al. Increase in the incidence of severe hypoglycaemia in people with type 2 diabetes in spite of new drugs: analysis based on health insurance data from Germany. Diabet Med . 2017;34(9):1212–1218. doi:10.1111/dme.13397 28586530
   PubMed Web of Science ®Google Scholar
• Kokoszka A , Kot W . Relationship of the patient age and intensity of type 2 diabetes treatment. Pol Arch Med Wewn . 2007;117(9):396–401.18062561
   PubMedGoogle Scholar
• Bonaventura A , Carbone S , Dixon DL , Abbate A , Montecucco F . Pharmacologic strategies to reduce cardiovascular disease in type 2 diabetes mellitus: focus on SGLT-2 inhibitors and GLP-1 receptor agonists. J Intern Med . 2019. doi:10.1111/joim.12890
   Web of Science ®Google Scholar
• Dekkers CCJ , Gansevoort RT , Heerspink HJL . New diabetes therapies and diabetic kidney disease progression: the role of SGLT-2 inhibitors. Curr Diab Rep . 2018;18(5):27. doi:10.1007/s11892-018-1107-0 29589183
   PubMed Web of Science ®Google Scholar
• Sajja AP , Dey AK , Guha A , Elnabawi Y , Joshi AA , Kalra A . SGLT-2 inhibitors and GLP-1 agonists: first-line therapy for diabetes with established cardiovascular disease. J Cardiovasc Pharmacol Ther . 2019;1074248419838511.
   Web of Science ®Google Scholar
• Walker RJ , Strom Williams J , Egede LE . Influence of race, ethnicity and social determinants of health on diabetes outcomes. Am J Med Sci . 2016;351(4):366–373. doi:10.1016/j.amjms.2016.01.008 27079342
   PubMed Web of Science ®Google Scholar
• Andermann A . Screening for social determinants of health in clinical care: moving from the margins to the mainstream. Public Health Rev . 2018;39:19. doi:10.1186/s40985-018-0094-7 29977645
   PubMed Web of Science ®Google Scholar